MoonLake Immunotherapeutics (MLTX)
46.76
+0.34
(+0.73%)
USD |
NASDAQ |
Nov 01, 16:00
46.48
-0.28
(-0.60%)
After-Hours: 20:00
MoonLake Immunotherapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Novartis AG | 0.6999 |
| AC Immune SA | 0.00 |
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | 0.00 |
| NLS Pharmaceutics Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 544.88M |
| Total Liabilities (Quarterly) | 14.85M |
| Shareholders Equity (Quarterly) | 520.66M |